Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Social Reward and its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 23, 2020
Register-Dependent Variability of Pitch and Amplitude Control in Singers
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 21, 2023
Head and Neck Patient Registry
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 17, 2024
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 21, 2024
Molecular Pathogenesis of Plasma Cell Disorder
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 11, 2024
ARO-021: Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 22, 2019
Long term Outcomes of Obese Patients with Gastrointestinal Complications of Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2019
Pembrolizumab and Stereotactic Radio Surgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 5, 2019
AGCT1532: Phase 3 Accelerated BEP Trial: A Randomized Phase 3 trial of Accelerated vs Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 22, 2019
DORA Trial: Phase 3 Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 13, 2019